132 results
424B4
SNGX
Soligenix Inc
19 Apr 24
Prospectus supplement with pricing info
4:05pm
in the development of products based on innovative or novel technologies. Specifically, each of the following is possible with respect to any of our product … Committee for Orphan Medical Products and Promising Innovative Medicine (“PIM”) designation from the MHRA, as well as Innovation Passport under
8-K
EX-99.1
anoygixg
15 Dec 22
Soligenix Announces Submission of New Drug Application to the FDA for HyBryte™ in the Treatment of Cutaneous T-cell Lymphoma
8:14am
8-K
EX-99.1
cs7z4p0u
20 Sep 21
Soligenix to Advance Synthetic Hypericin Development in Psoriasis
4:01pm